Guillain–Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report
Journal of Investigative Medicine High Impact Case Reports · 2025
DOI: 10.1177/23247096251388264 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Investigative Medicine High Impact Case Reports, 2025. Verfasst von Ali Falah Zbala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Al-Kindi College of Medicine, University of Baghdad, Iraq. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome, Lupus Erythematosus, Systemic. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disorder characterized by a wide spectrum of clinical features ranging from skin and joint involvement to organ dysfunction, including the central nervous system, peripheral nervous system (PNS), and renal failure. Guillain–Barré syndrome (GBS) is an immune-mediated acute polyradiculoneuropathy involving the PNS and represents an unusual initial manifestation of SLE. An 18-year-old female presented with subacute, progressive, ascending weakness of the lower and upper limbs, accompanied by hyporeflexia. Further clinical and laboratory evaluation revealed that the patient fulfilled the diagnostic criteria for SLE. Electromyography and nerve conduction studies demonstrated normal conduction velocities and latencies, but there was a reduced amplitude of compound motor action potentials in the distal muscles of the upper and lower limbs, without conduction block. Needle electromyography findings were consistent with a diagnosis of acute motor axonal neuropathy, considered a moderate-to-severe form of GBS. On evaluation, the patient exhibited polyarthralgia, widespread generalized erythematous rash, microcytic anemia, and bilateral pleural effusion. Immunological profiling revealed high-titer antinuclear antibody (1:1280), elevated anti-dsDNA (171 IU/mL), positive anti-Sm antibodies, and low C3/C4 levels. Treatment with pulse steroids (methylprednisolone 1 g/day for 3 days), immunosuppressants, and intravenous immunoglobulin led to marked improvement. This case emphasizes that SLE can precipitate GBS, and early recognition of this overlap may influence therapeutic strategies and improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Al-Kindi College of Medicine, University of Baghdad, Iraq.
- Al Diwaniyah Teaching Hospital, Iraq.
- College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
- College of Medicine, University of Basra, Iraq.
- Dhaka Medical College and Hospital, Bangladesh.
ORCID-Profile: Sajjad Ghanim Al-Badri, Ibrahim Khalil
Zitieren
APA
Zbala, A. F., Hadi, A. K., Al-Badri, S. G., Abbas, A. H., & Khalil, I. (2025). Guillain–Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report. Journal of Investigative Medicine High Impact Case Reports. https://doi.org/10.1177/23247096251388264
Vancouver
Zbala AF, Hadi AK, Al-Badri SG, Abbas AH, Khalil I. Guillain–Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report. Journal of Investigative Medicine High Impact Case Reports. 2025. doi:10.1177/23247096251388264
BibTeX
@article{Zbala2025,
author = {Zbala, Ali Falah and Hadi, Ahmed Kamel and Al-Badri, Sajjad Ghanim and Abbas, Abbas Hamza and Khalil, Ibrahim},
title = {Guillain–Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report},
journal = {Journal of Investigative Medicine High Impact Case Reports},
year = {2025},
doi = {10.1177/23247096251388264}
}
EUVIMED